TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Yazar: | Afroza, Halima |
---|---|
Diğer Yazarlar: | Talukder, Mesbah |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2024
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/22075 |
Benzer Materyaller
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Yazar:: Islam, Nahidul
Baskı/Yayın Bilgisi: (2023) -
Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
Yazar:: Tamanna, Shams Tahsin
Baskı/Yayın Bilgisi: (2020) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
Yazar:: Islam, S.M. Zahidul
Baskı/Yayın Bilgisi: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Yazar:: Khandker, Tahia Anjum
Baskı/Yayın Bilgisi: (2024) -
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
Yazar:: Akter, Anika
Baskı/Yayın Bilgisi: (2022)